Sacituzumab Govitecan as a Treatment Option for Patients with metastatic triple-negative Breast Cancer and impending Liver Failure: two Case Reports

被引：0
|
作者：
Wolf, E. E. [1 ]
Agabejli, S. [1 ]
Wimberger, P. [1 ]
Link, T. [1 ]
机构：
[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Inst Abt Gynakol & Geburtshilfe, Dresden, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 06期
关键词：
D O I：
10.1055/s-0043-1769875
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
66
引用
收藏
页码：E34 / E34
页数：1
相关论文
共 50 条
  • [41] Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
    Rugo, Hope S.
    Tolaney, Sara M.
    Loirat, Delphine
    Punie, Kevin
    Bardia, Aditya
    Hurvitz, Sara A.
    O'Shaughnessy, Joyce
    Cortes, Javier
    Dieras, Veronique
    Carey, Lisa A.
    Gianni, Luca
    Piccart, Martine J.
    Loibl, Sibylle
    Goldenberg, David M.
    Hong, Quan
    Olivo, Martin
    Itri, Loretta M.
    Kalinsky, Kevin
    NPJ BREAST CANCER, 2022, 8 (01)
  • [42] Sacituzumab govitecan response in extensive leptomeningeal carcinomatosis from triple-negative breast cancer: a case report
    Yaringano, Jesus
    Roca-Herrera, Maria
    Eremiev, Simeon
    Mascaro-Baselga, Pau
    Benito, Pau
    Nunez, Fidel
    Benavente, Sergi
    Pimentel, Isabel
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [43] Biomarker Evaluation in the Phase 3 ASCENT Study of Sacituzumab Govitecan vs Chemotherapy in Patients With Metastatic Triple-Negative Breast Cancer
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 6 - 7
  • [44] Sacituzumab govitecan in Japanese patients with metastatic triple-negative breast cancer: phase 2 results of ASCENT J02
    Naito, Y.
    Nakamura, S.
    Kawaguchi, N.
    Ishida, T.
    Nakayama, T.
    Yamamoto, Y.
    Masuda, N.
    Matsumoto, K.
    Kogawa, T.
    Sudo, K.
    Shimomura, A.
    Lai, C.
    Zhang, D.
    Iwahori, Y.
    Gary, D.
    Huynh, D.
    Iwata, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1326 - S1326
  • [45] Biomarker evaluation in the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
    Hurvitz, Sara A.
    Tolaney, Sara M.
    Punie, Kevin
    Loirat, Delphine
    Oliveira, Mafalda
    Kalinsky, Kevin
    Zelnak, Amelia
    Aftimos, Philippe
    Dalenc, Florence
    Sardesai, Sagar
    Hamiltion, Erika
    Sharma, Priyanka
    Recalde, Sabela
    Gil, Eva Ciruelos
    Traina, Tiffany
    O'Shaughnessy, Joyce
    Cortes, Javier
    Tsai, Michaela
    Vahdat, Linda
    Dieras, Veronique
    Carey, Lisa
    Rugo, Hope S.
    Goldenberg, David M.
    Hong, Quan
    Olivo, Martin
    Itri, Loretta M.
    Bardia, Aditya
    CANCER RESEARCH, 2021, 81 (04)
  • [46] Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
    Bardia, A.
    Tolaney, S. M.
    Punie, K.
    Loirat, D.
    Oliveira, M.
    Kalinsky, K.
    Zelnak, A.
    Aftimos, P.
    Dalenc, F.
    Sardesai, S.
    Hamilton, E.
    Sharma, P.
    Recalde, S.
    Gil, E. C.
    Traina, T.
    O'Shaughnessy, J.
    Cortes, J.
    Tsai, M.
    Vahdat, L.
    Dieras, V
    Carey, L. A.
    Rugo, H. S.
    Goldenberg, D. M.
    Hong, Q.
    Olivo, M.
    Itri, L. M.
    Hurvitz, S. A.
    ANNALS OF ONCOLOGY, 2021, 32 (09) : 1148 - 1156
  • [47] Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients
    Altundag, Kadri
    BREAST CANCER, 2024, 31 (04) : 735 - 735
  • [48] Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer Comment
    Rozenblit, Mariya
    Lustberg, Maryam B.
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (07)
  • [49] Exposure-response analyses of sacituzumab govitecan (SG) efficacy and safety in patients (pts) with metastatic triple-negative breast cancer (mTNBC).
    Singh, Indrajeet
    Sathe, Abhishek G.
    Singh, Pratap
    Diderichsen, Paul M.
    Fauchet, Floris
    Maringwa, John
    Pierrillas, Philippe
    Phan, See-Chun
    Girish, Sandhya
    Othman, Ahmed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Cost-effectiveness of Sacituzumab Govitecan versus Single-agent Chemotherapy for Patients with Metastatic Triple-Negative Breast Cancer in China
    Wang, Lei
    Liu, Lulu
    Zhang, Zhe
    Li, Fushu
    Ruan, Yi
    He, Yao
    Huang, Jingbin
    Zheng, Xiaoyuan
    CLINICAL BREAST CANCER, 2024, 24 (07)
12345